Bahleda, Rastislav; Italiano, Antoine; Hierro, Cinta; Mita, Alain; Cervantes, Andrés; Chan, Nancy; Awad, Mark; Moreno, Víctor; Tabernero, Josep
(American Association Cancer Research, 2019)
Purpose: Here, we report results of the first phase I study of erdafitinib, a potent, oral pan-FGFR inhibitor.
Patients and Methods: Patients age >= 18 years with advanced solid tumors for which standard antineoplastic ...